What this deck covers
This deck focuses on Storage And Handling, giving you a quick way to review the definitions, rules, and examples that matter most for NAPLEX.
Study Storage And Handling in NAPLEX with focused flashcards that help you recognize the idea, recall the key rule, and apply it in practice-style prompts.
0% Complete
What is the maximum beyond-use date for a single-dose container opened outside ISO 5 (USP <797>)?
Tap card or press Space to flip
Single-dose opened outside ISO 5: use within 1 hour. USP <797> restricts to 1 hour outside ISO 5 to minimize contamination risks in non-sterile environments.
How well did you know it?
Card 1 / 25
Space to flip · ← / → to move · once flipped, → Got it · ← Still learning
This deck focuses on Storage And Handling, giving you a quick way to review the definitions, rules, and examples that matter most for NAPLEX.
Work through these flashcards in short sessions. Try to answer each prompt before flipping the card, then revisit any cards you miss until the explanation feels automatic.
Answer: Single-dose opened outside ISO 5: use within 1 hour. USP <797> restricts to 1 hour outside ISO 5 to minimize contamination risks in non-sterile environments.
Answer: Do not crush or chew. Enteric-coated tablets must remain intact to ensure release in the intestine, avoiding gastric irritation or premature dissolution.
Answer: Protects from contamination by liquids/solids/vapors; loss/efflorescence. USP defines tight containers to safeguard contents from external contaminants and internal changes like efflorescence under normal handling.
Answer: Store in a designated area with containment strategies and restricted access. USP <800> mandates containment and restricted access to minimize exposure risks to hazardous drugs for personnel safety.
Answer: Controlled room temperature: 20–25∘C. USP defines controlled room temperature as 20-25°C to maintain medication stability under typical pharmacy conditions.
Answer: FEFO (first-expire, first-out) stock rotation. FEFO prioritizes expiring stock to ensure medications are used before expiration, reducing waste and safety risks.
Answer: Water-containing topical/dermal: BUD not later than 30 days. USP <795> sets a 30-day BUD for topical water-containing compounds to balance stability and contamination risks at room temperature.
Answer: Frozen: −25 to −10∘C. Freezing at -25 to -10°C ensures long-term stability for medications requiring ultra-low temperatures to prevent chemical breakdown.
Answer: Water-containing oral: BUD not later than 14 days refrigerated. USP <795> requires refrigeration and a 14-day BUD for water-containing orals to prevent microbial growth.
Answer: Dispense in tight container with desiccant when appropriate. Tight containers with desiccants absorb moisture, preventing hygroscopic drugs from absorbing water and losing potency.
Answer: Impermeable to air or other gases under ordinary conditions. USP hermetic containers seal against gases to maintain sterility or prevent oxidation in sensitive pharmaceutical products.
Answer: Tight container (moisture-resistant closure). Tight containers prevent moisture ingress, which could lead to hydrolysis or degradation of moisture-sensitive drugs.
Answer: Store above freezing; avoid ≤0∘C exposure. The label prevents freezing to avoid physical damage like crystallization or emulsion breaking in sensitive formulations.
Answer: Protects contents from effects of light. USP light-resistant containers block light transmission to avoid photochemical reactions that degrade drug efficacy.
Answer: Single-dose opened in ISO 5: use within 6 hours. USP <797> allows 6-hour use in ISO 5 to maintain sterility in controlled environments for compounded sterile preparations.
Answer: Keep in original container; protect from light and moisture. Sublingual nitroglycerin requires protection from light and moisture to prevent degradation and maintain potency.
Answer: Multi-dose vial after first puncture: 28 days unless manufacturer states otherwise. USP <797> defaults to 28 days post-puncture for multi-dose vials to prevent microbial contamination unless specified otherwise.
Answer: Unit-dose packaging (single-dose, ready-to-administer). Unit-dose packaging ensures accurate dosing, reduces errors, and complies with hospital standards for oral solids.
Answer: Protects from extraneous solids and loss under ordinary conditions. USP specifies well-closed containers to shield against solid contaminants and prevent content loss during routine storage and transport.
Answer: Store separately with restricted access and documented chain of custody. Separate storage with access controls and documentation ensures compliance, security, and traceability for clinical trials.
Answer: Non-aqueous: BUD not later than 6 months or earliest ingredient expiry. USP <795> limits BUD for non-aqueous compounds to minimize stability risks based on ingredient expiration.
Answer: USP <1>–<999>. USP chapters numbered below 1000 set mandatory, enforceable standards for pharmaceutical practices, including compounding, as established by regulatory bodies.
Answer: USP <1000>–<1999>. USP chapters in the 1000-1999 range offer non-mandatory guidance to support best practices without regulatory enforcement.
Answer: Refrigerated: 2–8∘C. Refrigeration at 2-8°C preserves medication integrity by slowing degradation processes that occur at higher temperatures.
Answer: Store in light-resistant container; minimize light exposure. The label requires light protection to prevent photodegradation, which can reduce drug potency or cause instability.